Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Growth Opportunities are Expected to Drive the Viral Vector Manufacturing Market’s CAGR Through 2034?

The viral vector manufacturing market has witnessed exponential growth in recent years. It is projected to grow from $6.93 billion in 2024 to $8.33 billion in 2025 at a CAGR of 20.1%. The past growth has been fueled by the expanding pipeline of gene therapies, clinical success and regulatory approvals, increasing investments in biopharmaceuticals, and the growing prevalence of genetic disorders.

The viral vector manufacturing market is forecasted to experience exponential growth, reaching $17.68 billion by 2029 at a CAGR of 20.7%. The primary growth drivers include expanding applications in oncology, increased global collaborations in gene therapy research, the adoption of viral vectors in vaccine development, and continued clinical trials and commercialization. Key emerging trends in this market include technological innovations in vector production, the development of next-generation vectors, a growing emphasis on regulatory compliance and standardization, increased partnerships and collaborations, and the global expansion of manufacturing facilities.

How Are the key drivers expanding the growth of the Market?

The growing prevalence of cancer and infectious diseases is predicted to propel the viral vector manufacturing market. Viral infections, caused by viruses or their byproducts, spread to humans and animals through contact with infected individuals or items. Cancer involves uncontrolled cell growth that can invade nearby organs. Viral vectors have been used in the development of vaccines for infectious diseases and cancer treatments by producing tumor antigens to trigger immune responses. For example, the Australian Institute of Health and Welfare reported in July 2024 that cancer cases in Australia increased from 160,570 in 2022 to 164,694 in 2023, marking a significant rise. Additionally, a report from the UK Health Security Agency in August 2024 showed a sevenfold increase in measles cases in England in 2023. Therefore, the rising incidence of cancer and infectious diseases is fostering the growth of the viral vector manufacturing market.

Get Your Free Sample of the Global Viral Vector Manufacturing Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=12398&type=smp

What Are the Leading Industry Players Dominating the Viral Vector Manufacturing Market?

Major companies operating in the viral vector manufacturing market include:

• Sanofi S.A._x000D_

• Thermo Fisher Scientific Inc._x000D_

• Merck Group_x000D_

• FUJIFILM Holdings Corporation_x000D_

• Lonza Group_x000D_

What Are the Latest Trends Leading to Disruption in the Viral Vector Manufacturing Market?

Innovation remains a key trend in the viral vector manufacturing market, where companies are introducing cutting-edge solutions to strengthen their market position. For example, in August 2022, Merck KGaA launched the VirusExpress 293 AAV Production Platform, offering a complete viral vector manufacturing package. This platform enables biopharmaceutical companies to accelerate the clinical manufacturing process while optimizing cost-efficiency and development speed.

Get Instant Access to the Global Viral Vector Manufacturing Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/viral-vector-manufacturing-global-market-report

Which Key Segments Define the Structure of the Viral Vector Manufacturing Market and Their Growth Potential?

The viral vector manufacturing market covered in this report is segmented –

1) By Type: Adenoviral Vectors, Adeno-Associated Viral Vectors, Lentiviral Vectors, Retroviral Vectors, Other Types

2) By Disease: Cancer, Genetic Disorders, Infectious Diseases, Other Diseases

3) By Workflow: Upstream Processing, Downstream Processing

4) By Application: Gene And Cell Therapy Development, Vaccine Development, Biopharmaceutical And Pharmaceutical Discovery, Biomedical Research

5) By End-User: Research Organizations, Biotech And Pharmaceutical Companies, Others End Users

Subsegments:

1) By Adenoviral Vectors: Serotype 5, Serotype 2, Serotype 26

2) By Adeno-Associated Viral Vectors: AAV2, AAV5, AAV8, AAV9, Others

3) By Lentiviral Vectors: HIV-1-Based Lentiviral Vectors, SIV-Based Lentiviral Vectors, Others

4) By Retroviral Vectors: Moloney Murine Leukemia Virus (MoMLV), Gammaretroviral Vectors, Others

5) By Other Types: Sendai Viral Vectors, Vesicular Stomatitis Virus (VSV)-Based Vectors, Measles Virus Vectors, Others

Which Regions Are Significant to the Growth of the Viral Vector Manufacturing Market?

North America was the largest region in the viral vector manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral vector manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

How Can We Define the Viral Vector Manufacturing Market and Its Key Components?

Viral vector manufacturing refers to producing viral vectors, tools that deliver genetic material into cells. A viral vector is a tool for gene transfer that can manipulate a particular cell type or tissue to express therapeutic genes.

Browse Through More Similar Reports By The Business Research Company:

Thrust Vector Control Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/thrust-vector-control-global-market-report

Recombinant DNA Technology Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/recombinant-dna-technology-global-market-report

Viral Vectors And Plasmid DNA Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/viral-vectors-and-plasmid-dna-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: